Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,020 | -86,064 | -41,518 | -143,948 | -101,992 |
| Depreciation Amortization | 12,125 | 7,979 | 3,888 | 8,233 | 6,444 |
| Accounts receivable | N/A | 0 | N/A | N/A | -2,000 |
| Accounts payable and accrued liabilities | -2,376 | -3,471 | -930 | 1,614 | -3,036 |
| Other Working Capital | -18,850 | -16,149 | -10,213 | 20,121 | -38,699 |
| Other Operating Activity | 20,288 | 16,049 | 6,822 | 32,615 | 31,229 |
| Operating Cash Flow | $-123,833 | $-81,656 | $-41,951 | $-81,365 | $-108,054 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,168 | -4,821 | -2,884 | -8,401 | -5,816 |
| Purchase Of Investment | -409,738 | -279,921 | -54,803 | -246,334 | -157,941 |
| Sale Of Investment | 300,010 | 189,185 | 93,200 | 323,036 | 246,431 |
| Investing Cash Flow | $-116,896 | $-95,557 | $35,513 | $68,301 | $82,674 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 285,161 | 239,391 | 1,624 | 3,217 | 3,210 |
| Common Stock Repurchased | -15 | -15 | N/A | N/A | N/A |
| Financing Cash Flow | $285,146 | $239,376 | $1,624 | $3,217 | $3,210 |
| Beginning Cash Position | 55,528 | 55,528 | 55,528 | 65,375 | 65,375 |
| End Cash Position | 99,945 | 117,691 | 50,714 | 55,528 | 43,205 |
| Net Cash Flow | $44,417 | $62,163 | $-4,814 | $-9,847 | $-22,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,833 | -81,656 | -41,951 | -81,365 | -108,054 |
| Capital Expenditure | -7,168 | -4,821 | -2,884 | -8,401 | -5,816 |
| Free Cash Flow | -131,001 | -86,477 | -44,835 | -89,766 | -113,870 |